Penelope MacRae
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Penelope MacRae
India Leads Global 65% Surge In Antibiotics Use
Human antibiotic consumption globally jumped dramatically between 2000 and 2015, with India posting the biggest rise, reports a new US study, which calls for a radical policy rethink to prevent antimicrobial drug resistance soaring.
Daiichi Demands Court Block Fortis Sale Until Singhs Pay $550m Arbitration Award
Hilleman Eyes Bangladesh Approval Of Novel, Cheaper Cholera Vaccine This Year
Indian vaccine research organization Hilleman Laboratories says it is hoping to get its "new design", cheaper cholera vaccine licensed in Bangladesh this year and that the next step will be to seek to make it available to UN agencies amid remaining global inoculation need.
IIL's Combo Vaccine Wins Big Indian Tender, But Pentavalent Concerns Linger
State-owned Indian Immunologicals Ltd., one of the local companies aiming to challenge the dominance of multinationals in the domestic Indian vaccine market, has come up with a low-priced five-in-one jab for children that the government is including in its massive national immunization program.
Call For India Compulsory Licenses For Last Resort TB Drugs
Public health campaigners in India and globally are pushing the government to allow Indian generic firms to make cheap copies of two new-generation, last resort antibiotics for drug-resistant tuberculosis through the use of patent-busting compulsory licenses.
Zydus Partners Medicure To Launch First Branded Drug In US
Zydus Cadila is teaming up with Canada’s Medicure Inc to launch cholesterol control medication Zypitamag, its first branded drug in the key US market, as the Indian firm drives ahead with a strategy of diversifying from low-priced generics.